These success, together with a prior report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 aid the strategy of targeting ACKR3 as a novel strategy to modulate the opioid system, which could open up new therapeutic avenues for opioid-similar disorders. Long-term discomfort is advanced, and https://conolidine21953.blogdon.net/rumored-buzz-on-conolidine-49764886